Client News
Filter by:
- Oct 30 2019 Highpower International Announces Results of Special Meeting of Stockholders
- Oct 24 2019 Highpower International Reminds Stockholders Voting Channel Remains Open for Special Meeting to be held on October 29, 2019
- Oct 17 2019 Glass Lewis Joins ISS in Recommending Stockholders Vote FOR Highpower International's Merger
- Oct 15 2019 ISS recommends Stockholders Vote FOR Highpower International's Merger
- Aug 1 2019 Bion Issues 2019 Mid-Year Update and Outlook
- Jul 29 2019 Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression
- Jul 23 2019 Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial for Iomab-B
- Jul 11 2019 Actinium Highlights Two Presentations at the Health Physics Society Annual Meeting Supporting the Safety Profile of Iomab-B for SIERRA Trial Caregivers
- Jun 27 2019 Bion Announces Key Legislation Approved in Pennsylvania Senate
- Jun 26 2019 Actinium Poster Detailing Actinium-225 Labeled Daratumumab Selected in Top Poster Award Competition at 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting